FGF2 and Kaposi's sarcoma: Several lines of evidence suggest that KS is an angiogenic and inflammatory cytokine-mediated driven disease; at least in early stages, and that angiogenic factors and; in particular, bFGF, play a role in lesion development [70, 71].